bioRxivImmunology
High glucose enhances antigen-independent CTL killing via TRAIL
W. Yang, A. Denger, C. Diener, F. Kueppers, L. Soriano-Baguet, G. Schaefer, A. K. Yanamandra, R. Zhao, A. Knoerck, E. C. Schwarz, M. Hart, F. Lammert, L. P. Roma, D. Brenner, G. Grigorios Christidis, V. Helms, E. Meese, M. Hoth, B. Qu
Abstract
Cytotoxic T lymphocytes (CTLs) are involved in development of diabetes. However, the impact of excessive glucose on CTL-mediated antigen-independent killing remains elusive. Here, we report that TNF-related apoptosis inducing ligand (TRAIL) is substantially up- regulated in CTLs in environments with high glucose (HG) both in vitro and in vivo. The PI3K- Akt-NF{kappa}B axis and non-mitochondrial reactive oxygen species are essential in HG-induced TRAIL upregulation in CTLs. TRAILhigh CTLs induce apoptosis of pancreatic beta cell line 1.4E7. Metformin and Vitamin D synergistically reduce HG-enhanced expression of TRAIL in CTLs and coherently protect 1.4E7 cells from TRAIL-mediated apoptosis. Notably, in patients with diabetes, correlation between Vitamin D concentrations in plasma and glucose levels is linked to HG-enhanced TRAIL expression on CTLs. Microarray data reveal that OXCT2, an important enzyme in ketone body catabolism, is a promising target in response to vitamin D. Our work not only reveals a novel mechanism of CTL involvement in progression of diabetes, but also establishes CTLs as a target for combined metformin and vitamin D therapy to protect pancreatic beta cells of diabetic patients.
- organism: human
- assay: proteomics
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- High glucose attenuates Ca2+ influx in cytotoxic T lymphocytes upon target recognition
H. Zou, G. Schwaer, … B. Qu·bioRxiv·Apr 9, 2020
- Human CD8+ T-cells Require Glycolysis to Elicit Effector Function
S. E. Stimpson, J. Chen, … C. E. Mathews·bioRxiv·Feb 5, 2020
- Glucose-Responsive CD20+ Cytotoxic T Cells: A Novel Pro-inflammatory Mediator in the Immunopathogenesis of Type 2 Diabetes
Özgür Albayrak, Adnan Batman, … Atay Vural·bioRxiv·Feb 13, 2026
- Activation of T cell checkpoint pathways during beta-cell antigen presentation by engineered dendritic cells promotes protection of non-obese diabetic mice from type 1 diabetes
R. R. Gudi, N. Perez, … C. Vasu·bioRxiv·Aug 8, 2021
- Inhibition of formate production blocks CD8+ T-cell responses and delays disease onset in a mouse model of type 1 diabetes
Erika Gabriela Ramirez-Hernandez, Micah Bell, … Nora Kory·bioRxiv·Jul 4, 2025
- Non-canonical Hedgehog signaling through L-type voltage gated Ca2+ channels controls CD8+ T cell killing
J. Hanna, C. Kapeni, … M. de la Roche·bioRxiv·Mar 1, 2021